Jci_page_head_homepage_01 Jci_page_head_homepage_02
Li Liu, Yiying Zhang, Nancy Chen, Xiaojing Shi, Bonny Tsang, Yi-Hao Yu
Published in Volume 117, Issue 6
J Clin Invest. 2007; 117(6):1679–1689 doi:10.1172/JCI30565
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
Models for fat-induced insulin resistance in obesity and protection by exercise-induced augmentation of TG synthesis.

This model assumes that excessive accumulation of certain intramyocellular FA-derived lipid metabolites is lipotoxic and is a cause for muscle insulin resistance. In this model, both the terminal catabolic pathway (CAT) of FA oxidation and the anabolic pathway (ANA) of TG synthesis are viewed as beneficial in removing potentially lipotoxic FA derivatives from myocytes. In obesity, the primary driving force for increased myocellular TG levels is FA overload of myocytes. Because of the increased intracellular FA substrates, not only are TG levels increased, but levels of lipotoxic FA derivatives are also increased, leading to muscle insulin resistance. Exercise upregulates DGAT1, which increases the TG synthesis capacity. This also increases TG formation but reduces FA substrate levels, resulting in decreased formation of lipotoxic FA derivatives. Thus, upregulation of myocellular DGAT1 is protective against FA-induced insulin resistance.